Is Clover Health a Disruptor or Distractor?
Clover Health (NASDAQ: CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia.
In this episode of Industry Focus: Wildcard, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover's business and its unique value proposition, and then debate whether the controversial short-seller report should have investors running for the door.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks . A full transcript follows the video.
Source Fool.com
